Zimbabwe has rejected a significant US health deal worth $367m (£272m) over five years over the United States' demand for sensitive biological samples.
The decision became public after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".
An official representative later explained that the US was demanding access to health data for scientific study and commercial gain while was not willing to share the resulting advantages from any future vaccines.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further talks to reach a deal acceptable to both sides so the country's critical HIV programme can be sustained.
Wider Context
This development comes after a similar situation in Kenya, where a court blocked a similar health funding agreement after legal challenges were filed about the security of Kenyans' health data.
After resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.
Based on statements, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," his statement read.
"Put simply, our country would provide the raw materials for medical research with no certainty that the end products would be accessible to our people if a new health crisis arise."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending structures already set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.
"This system is intended to guarantee that when a country provides its data, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how subsequent collaboration might be structured in a manner that honours the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks need to persist given that much of the nation's Aids initiatives depended on foreign aid.
"If technical issues arise, such as those relating to information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.
The halted deal underscores the continuing debate between receiving crucial international aid and safeguarding local interests in an ever more interconnected world.